China SXT Pharmaceuticals, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | 65.8% | 25.2% | 22.0% |
| FY2020 | 52.4% | -26.0% | -199.3% |
| FY2021 | 59.4% | -46.0% | -57.5% |
| FY2022 | 48.1% | -199.4% | -220.4% |
| FY2023 | 21.6% | -284.4% | -301.0% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | 65.8% | 25.2% | 22.0% |
| FY2020 | 52.4% | -26.0% | -199.3% |
| FY2021 | 59.4% | -46.0% | -57.5% |
| FY2022 | 48.1% | -199.4% | -220.4% |
| FY2023 | 21.6% | -284.4% | -301.0% |